Table 1 The baseline of clinical characteristic of this study (excluded Cholecystomy)

Gender (male/female)

9 (28.1%)/23 (71.9%)

31 (21.5%)/113 (78.5%)

14 (53.8%)/12 (46.2%)

Age

29.9 ± 10.73

27.29 ± 8.61

30.92 ± 9.07

Weight (Kg)

107.8 ± 22.6

99.8 ± 19.8

111.3 ± 23.0

BMI

37.5 ± 5.2

36.2 ± 4.82

36.9 ± 4.01

HbA1c (%)

6.41 ± 1.09

5.39 ± 0.35

7.2 ± 1.14

Insulin (pmol/L)

26.5 ± 12.5

19.9 ± 12.3

23.8 ± 7.9

C-peptid e (ug/L)

3.8 ± 1.08

3.25 ± 1.31

4.39 ± 2.74

Glucose (mmol/L)

5.9 ± 1.03

5.08 ± 0.53

8.3 ± 2.67

TBA (umol/L)

4.3 ± 4.07

4.06 ± 4.69

3.77 ± 2.2

CHOL (mmol/L)

5.1 ± 0.99

4.9 ± 0.89

5.2 ± 1.47

TG (mmol/L)

2.3 ± 2.21

1.71 ± 0.91

2.23 ± 1.06

LDL (mmol/L)

3.2 ± 0.68

3.02 ± 0.74

3.5 ± 0.97

HDL (mmol/L)

0.99 ± 0.22

1.1 ± 0.29

1.0 ± 0.16

ALT (U/L)

69.2 ± 41.2

41.7 ± 40.89

74.4 ± 47.2

AST (U/L)

40.0 ± 22.7

26.8 ± 18.59

45.1 ± 26.8